Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 3, 1998, Pages 269-280

  Gorodetsky, Raphael ^a   Vexler, Akiva ^b   An, Jianqiang ^b   Mou, Xiaode ^b   Marx, Gerard ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032033425     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90100-7     Document Type: Article

References (42)

1. Schlag G, Redl H, editors. Fibrin sealant in operative medicine (vol 3). Berlin: Springer Verlag, 1986.
2. Gibble JW, Ness PM. Fibrin glue: the perfect operative sealant? Transfusion 1990;30:741-7.
3. Matthew T, Sponitz W, Kron I, Daniel T, Tribble C, Nolan S. Four years' experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 1990;50:40-4.
4. Burnouf-Radosevich M, Burnouf T, Huart JJ. Biochemical and physical properties of a solvent-detergent-treated fibrin glue. Vox Sang 1990;58:77-84.
5. Chin S, Williams B, Gottlieb P, Margolis-Nunno H, Ben-Hur E, Hamman J, et al. Virucidal UVC treatment of plasma and factor VIII concentrate: protection of proteins by antoxidants. Blood 1995;86:4331-6.
6. Marx G, Mou X, Freed R, Ben-Hur E, Yang C, Horowitz B. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation. Photochem Photobiol 1996;63:541-6.
7. Senior RM, Skogen WF, Griffin GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986;77: 1014-9.
8. Clark RAF, Lanigan JM, DellaPelle P, Manseau E, Dvorak H, Colvin RB. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound re-epithelialization. J Invest Dermatol 1982;79:624-9.
9. Ciano PS, Colvin RB, Dvorak AM, McDonagh J, Dvorak HF. Macrophage migration in fibrin gel matrices. Lab Invest 1986;54:62-9.
10. Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Hematol 1976;32:507-13.
11. Lorenzet R, Sobel JH, Bini A, Witte LD. Low molecular weight fibrinogen degradation products stimulate the release of growth factors from endothelial cells. Thromb Haemost 1992;68:357-63.
12. Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol 1993;142:273-83.
13. Noel A, Munaut C, Nusgens B, Foidart JM, Lapiere CM. The stimulation of fibroblasts collagen synthesis by neoplastic cells modulated by the extracellular matrix. Matrix 1992;12: 213-20.
14. Gorodetsky R, McBride WH, Withers HR, Miller GG. Effect of fibroblast implants on wound healing of irradiated skin: assay of wound strength and quantitative immunohistology of collagen. Radiat Res 1991;125:181-6.
15. Xu J, Clark RAF. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996;132:239-49.
16. Sower LE, Froelich CJ, Carney DH, Fenton JW II, Klimpel GR. Thrombin induces IL-6 production in fibroblasts and epithelial cells. J Immunol 1995;155:895-901.
17. Armstrong MT, Fenton II JW, Andersen TT, Armstrong P. Thrombin stimulation of matrix fibronectin. J Cell Physiol 1996;166:112-20.
18. Katagiri Y, Hiroyama T, Akamatsu N, Sizuki H, Yamazaki H, Tanoue K. Involvement of αVβ3 integrin in mediating fibrin gel retraction. J Biol Chem 1995;270:1785-90.
19. Hayakawa Y, Tazawa S, Ishikawa T, Niya K, Sakuragawa N. Thrombin regulation of tissue-type plasminogen activator synthesis on cultured human fetal lung fibroblasts. Thromb Res 1993;71:457-65.
20. Dawes KE, Gray AJ, Laurent GJ. Thrombin stimulates fibroblast chemotaxis and replication. Eur J Cell Biol 1993;61: 126-30.
21. Stiernberg J, Redin WR, Warner WS, Carney DH. The role of thrombin and thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb Haemost 1993;70:158-62.
22. Gray AJ, Reeves JT, Harrison NK, Winlove P, Laurent GJ. Growth factors for human fibroblasts in the solute remaining after clot formation. J Cell Sci 1990;96:271-4.
23. Glenn KC, Carney DH, Fenton JW, Cunningham DD. Thrombin active site regions required for fibroblast receptor binding and initiation of cell division. J Biol Chem 1990;255:6609-16.
24. Ronnov-Jessen L, Celis JE, Van-Deurs B, Petersen OW. A fibroblast-associated antigen: characterization in fibroblasts and immunoreactivity in smooth muscle differentiated stromal cells. J Histochem Cytochem 1992;40:475-86.
25. Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW, Wilner GD, et al. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul 1990;1:453-63.
26. Ben-Bassat H, Eldad A, Chaouat M, Livoff A, Ron N, Neeman Z, et al. Structural and functional evaluation of modifications in the composite skin graft: cryopreserved dermis and cultured keratinocytes. Plast Reconstr Surg 1992;89:510-20.
27. Razin E, Marx G. Thrombin-induced degranulation of cultured bone marrow-derived mast cells. J Immunol 1984;133:3282-5.
28. Vlodavsky I, Greenburg G, Johnson LK, Gospodarowicz D. Vascular endothelial cells maintained in the absence of fibroblast growth factor undergo structural and functional alterations that are incompatible with their in vivo differentiated properties. J Cell Biol 1979;83:468-86.
29. Ramu A, Ramu N, Gorodestsky R. Reduced oubain resistant potassium entry as a possible mechanism of multidrug-resistance in p388 cells. Biochem Parmacol 1992;42:1699-704.
30. Horowitz AT, Treves AJ, Voss R, Okon E, Fuks Z, Davidson L, et al. A new human carcinoma cell line: establishment and analysis of tumor associated markers. Oncology 1985;42:332-7.
31. Rockwell S. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumor cells in vivo and in vitro. Br J Cancer 1978;37:212-5.
32. Ringel I, Roy SN, Horwitz SB. A phosphoglycoprotein associated with taxol resistance in J774.2 cells. Cancer Res 1985; 45:3856-63.
33. Vexler AM, Mou X, Gabizon A, Gorodetsky R. Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. Int J Cancer 1995;60:611-5.
34. Scudiero DA, Shoemaker RH, Paul KD, Monks A, Tierney S, Nofziger TH, et al. Evaluation of a soluble tetrazolium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988; 48:4827-33.
35. Clark RAF, editor. The molecular and cellular biology of wound repair. 2nd ed. New York: Plenum Press, 1996.
36. Santulli R, Derian C, Darrow AL, Tomko KA, Eckardt AJ, Seinberg M, et al. Evidence for the presence of a protease-activator receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 1995; 92:9151-5.
37. Hicks RC, Ellis M, Mir-Hasseine R, Higman DJ, Nott D, Greenhalgh RM, et al. The influence of fibrinogen concentration on the development of vein graft stenoses. Eur J Vasc Endovasc Surg 1995;9:415-20.
38. Connoly AJ, Ishihara H, Khan ML, Farese RV Jr, Coughlin SR. Role of thrombin receptor in development and evidence for a second receptor. Nature 1996;381:516-9.
39. Noda-Heiny H, Sobel BE. Vascular smooth muscle cell migration mediated by thrombin and urokinase receptor. Am J Physiol 1995;268:1195-201.
40. Thompson WD, Smith EB, Stirk CM, Marshall FI, Stout AJ, Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. Eur J Pathol 1992;168:47-53.
41. Saldeen T. Vasoactive peptides derived from degradation of fibrinogen and fibrin. Proc NY Acad Sci USA 1983;408:424-31.
42. Bachhuber BG, Sarembock IJ, Gimple LW, McNamara CA, Owens GK. Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am J Physiol 1995;268:1141-7.